Consistent with our findings, several sporadic studies reported elevated expression of PSMB8 in AML, likely due to the influence of the long noncoding RNA–HLA complex P5 (HCP5), and this elevation correlated with poor clinical outcomes [36,37,38,39]. The gene discussed is HCP5; the disease is acute myeloid leukemia.